本页面由Tiger Trade Technology Pte. Ltd.提供服务

NovoCure Limited

14.72
+0.14000.96%
盘后:14.720.00000.00%16:26 EDT
成交量:78.20万
成交额:1,144.60万
市值:17.14亿
市盈率:-11.25
高:14.76
开:14.54
低:14.26
收:14.58
52周最高:21.45
52周最低:9.82
股本:1.16亿
流通股本:9,642.36万
量比:0.35
换手率:0.81%
股息:- -
股息率:- -
每股收益(TTM):-1.3082
每股收益(LYR):-1.2221
净资产收益率:-43.22%
总资产收益率:-9.26%
市净率:5.07
市盈率(LYR):-12.05

数据加载中...

2024/09/03

重要事件披露

Form 8-K - Current report
2024/07/25

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/25

重要事件披露

Form 8-K - Current report
2024/07/10

SEC问询函

Form CORRESP - Correspondence
2024/07/10

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/06/10

重要事件披露

Form 8-K - Current report
2024/05/20

重要事件披露

Form 8-K - Current report
2024/05/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/02

重要事件披露

Form 8-K - Current report
2024/03/27

重要事件披露

Form 8-K - Current report
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities